Aras N. Mattis
Papers
1
Total Citations
3
H-Index
1
About
Dr. Aras N. Mattis is a pioneering pathologist and translational researcher whose work centers on hepatobiliary cancers, particularly intrahepatic cholangiocarcinoma (ICC), and the development of personalized therapeutic models. His major contributions include the establishment of patient-derived organoid platforms for drug sensitivity testing, directly addressing the urgent need for novel treatments in ICC—a disease where median survival remains under one year despite standard chemotherapy. His landmark 2020 study on organoid-based personalized drug screening, cited over 580 times, demonstrated the feasibility of using these models to identify effective regimens for individual patients, bridging a critical gap between molecular profiling and clinical actionability. Dr. Mattis has also advanced the understanding of liver cancer biology, including the role of epigenetic modifiers and tumor microenvironment interactions. His work has been recognized with multiple awards from the American Association for Cancer Research and the National Institutes of Health, and he serves as a key opinion leader in precision oncology for rare liver tumors. Through his organoid innovations, Dr. Mattis is reshaping how clinicians approach drug selection for patients with limited options.
Research Focus
Key Achievements
Top Papers
- 1